Pneumatosis intestinalis induced by osimertinib in a patient with lung adenocarcinoma harbouring epidermal growth factor receptor gene mutation with simultaneously detected exon 19 deletion and T790 M point mutation: a case report

BACKGROUND: Pneumatosis intestinalis is a rare adverse event that occurs in patients with lung cancer, especially those undergoing treatment with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI). Osimertinib is the most recently approved EGFR-TKI, and its usage is increasing in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nukii, Yuki, Miyamoto, Atsushi, Mochizuki, Sayaka, Moriguchi, Shuhei, Takahashi, Yui, Ogawa, Kazumasa, Murase, Kyoko, Hanada, Shigeo, Uruga, Hironori, Takaya, Hisashi, Morokawa, Nasa, Kishi, Kazuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394003/
https://www.ncbi.nlm.nih.gov/pubmed/30819142
http://dx.doi.org/10.1186/s12885-019-5399-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394003/
https://www.ncbi.nlm.nih.gov/pubmed/30819142
http://dx.doi.org/10.1186/s12885-019-5399-5

Ejemplares similares